Clever Leaves Holdings Inc. (OTCPK: CLVR)
Health Care · Pharmaceuticals · CO
$0.00
+19900.00% today · -33.3% 1Y
Clever Leaves Holdings Inc. (OTCPK: CLVR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $351.00 and employs 296 people.
Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.50.
Tweenvest scores Clever Leaves Holdings Inc. across four factors: quality 27/100, value 46/100. Its strongest factor is value.
CLVR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $351.00
- Revenue (TTM)
- $17.42M
- P/E
- —
- EPS
- -11.42
- Dividend yield
- —
- Beta (5Y)
- 1,062.15
- 52-week high
- $0.50
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.75M
- Employees
- 296
- Next earnings
- —
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. is a company primarily focused on the cannabis sector. Its operations are structured into two distinct divisions: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment oversees the global cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid-based products. In contrast, the Non-Cannabinoid segment, operating within the United States, specializes in the formulation, production, marketing, sales, and delivery of a diverse array of nutraceuticals, natural remedies, wellness items, detoxification solutions, and various nutritional and dietary supplements. These products are supplied to a broad clientele, including mass retailers, specialized health stores, and distributors. The company was founded in 2017 and is headquartered in Boca Raton, Florida.
- ISIN
- CA1867602031
- Founded
- 2017
- Listed since
- Dec 18, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.